-
GPCR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Structure Therapeutics (GPCR)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 169.51 mm | 169.51 mm | 169.51 mm | 169.51 mm | 169.51 mm | 169.51 mm |
Cash burn (monthly) | 873.33 k | (no burn) | 15.69 mm | 13.19 mm | 12.16 mm | 9.72 mm |
Cash used (since last report) | 3.15 mm | n/a | 56.62 mm | 47.59 mm | 43.87 mm | 35.08 mm |
Cash remaining | 166.36 mm | n/a | 112.89 mm | 121.92 mm | 125.64 mm | 134.43 mm |
Runway (months of cash) | 190.5 | n/a | 7.2 | 9.2 | 10.3 | 13.8 |
13F holders | Current |
---|---|
Total holders | 167 |
Opened positions | 31 |
Closed positions | 26 |
Increased positions | 63 |
Reduced positions | 50 |
13F shares | Current |
---|---|
Total value | 1.59 tn |
Total shares | 63.07 mm |
Total puts | 518.80 k |
Total calls | 973.40 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Wellington Management | 7.79 mm | $211.15 bn |
FMR | 6.08 mm | $164.86 bn |
JHG Janus Henderson | 4.16 mm | $112.82 bn |
Capital Research Global Investors | 3.54 mm | $95.93 bn |
Deep Track Capital | 2.80 mm | $75.94 bn |
Biotechnology Value Fund L P | 2.44 mm | $82.51 mm |
Driehaus Capital Management | 2.06 mm | $55.80 bn |
FHI Federated Hermes | 2.05 mm | $55.49 bn |
BVF | 1.77 mm | $48.04 bn |
Vestal Point Capital | 1.73 mm | $46.78 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 25 | Crespo Blas Coll | Ordinary Shares | Grant | Acquire A | No | No | 0 | 116,988 | 0.00 | 219,588 |
15 Mar 25 | Crespo Blas Coll | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 7.02 | 284,241 | 2.00 mm | 284,241 |
15 Mar 25 | Ashley Hall | Ordinary Shares | Grant | Acquire A | No | No | 0 | 51,048 | 0.00 | 118,338 |
15 Mar 25 | Ashley Hall | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 7.02 | 124,032 | 870.70 k | 124,032 |
15 Mar 25 | Yingli Ma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 63,810 | 0.00 | 100,539 |
15 Mar 25 | Yingli Ma | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 7.02 | 155,040 | 1.09 mm | 155,040 |
15 Mar 25 | Xichen Lin | Ordinary Shares | Grant | Acquire A | No | No | 0 | 80,829 | 0.00 | 166,536 |
15 Mar 25 | Xichen Lin | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 7.02 | 196,386 | 1.38 mm | 196,386 |
15 Mar 25 | Jun Yoon | Ordinary Shares | Grant | Acquire A | No | No | 0 | 170,166 | 0.00 | 1,293,299 |
15 Mar 25 | Jun Yoon | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 7.02 | 413,445 | 2.90 mm | 413,445 |